fb88 CDC Health Advisory

March 2, 2023

Increase in Extensively Drug-Resistant Shigellosis in the United States

Please take a moment to review this information from U.S. CDC that includes key recommendations for health providers, laboratories, and the general public. The United States has seen a rise in extensively drug-resistant shigellosis. In 2022, fb88 CDC identified 11 cases of shigellosis (preliminary data as of February 28, 2023). Shigellosis is a reportable disease in the State of fb88. All Shigella isolates and specimens are required to be sent to the fb88 Health and Environmental Testing Laboratory.

Advisory (PDF)